PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Amdocs Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Amdocs Limited's yearly results (2022–2025), compared with Technology companies in United States. Tap ? on any ratio for what it means.

Where $100 of sales goes

$82Operating costs$0.9Interest$12Net profit$5.0Paid as dividends

Latest year (Sep 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$144

Over the last 3 years, every $100 of reported profit came with $144 of operating cash.

Lower than 64% of Technology companies in United States.

Self-Funding Ratio

6.9×

Over the last 3 years its own operating cash covered its investment spending (capex) 6.9 times.

Higher than 71% of Technology companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

2/3 · 1/3

Sales grew in 2 of the last 3 years; profit grew in 1 of 3.

Less steady than 66% of Technology companies in United States.

Growth Efficiency Ratio

—

Sales barely changed

Sales changed by -1% in 3 years, too little to measure extra profit per extra sales.

Asset Productivity Ratio

-1% / -2%

In 3 years sales changed by -1% while total assets changed by -2%. Both moved at about the same pace.

Balance-sheet strength

Debt Due Cover Ratio

19.3×

Debt due within a year is covered 19.3 times by its yearly operating cash.

Higher than 74% of Technology companies in United States.

Cash Cushion Ratio

−8%

Debt, after subtracting cash, equals 8% of its market value (net debt).

Lower than 68% of Technology companies in United States.

Tangible Assets Ratio

51%

Of every $100 the company owns, $51 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 77% of Technology companies in United States.

Tangible Net Worth Ratio

11%

Of every $100 of net worth, $11 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 67% of Technology companies in United States.

Shareholders

Shareholder Slice Ratio

−10%

Share count fell 10% in 3 years (buybacks), so each share's slice of the company became larger. Dividends paid equalled 40% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Amdocs Limited owes $0.48 for every $1 it owns. Net profit rose 14% in the year to Sep 2025, and grew 1% a year on average over 3 years.

Compared with Technology companies in United States · latest annual results Sep 2025.

P/E ratio

15.1

Investors pay $15.1 for every $1 of Amdocs Limited's yearly profit, lower than 84% of Technology companies in United States.

P/B ratio

2.02

The share price is 2.02 times Amdocs Limited's book value per share, lower than 68% of Technology companies in United States.

Market cap

$6.6 B

The total market value of all of Amdocs Limited's shares at today's price (share price × number of shares), larger than 73% of Technology companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$3.3 B

What Amdocs Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$31.48

Net worth divided by the number of shares. The share price of $63.57 is 2.0 times this, which is the P/B above.

Return on equity (ROE)

13.3%

Amdocs Limited earned 13.3% on its shareholders' money over the last year, higher than 70% of Technology companies in United States.

Owes vs Owns

0.48×

Amdocs Limited owes $0.48 for every $1 it owns (low), higher than 52% of Technology companies in United States.

Dividend yield

3.70%

Amdocs Limited pays 3.70% of its share price as dividends a year, higher than 91% of dividend-paying Technology companies in United States.

Revenue growth

-9%

Revenue fell 9% in the year to Sep 2025, and shrank 0% a year on average over 3 years.

Profit growth

+14%

Net profit rose 14% in the year to Sep 2025, and grew 1% a year on average over 3 years.

Profit margin

12.5%

Amdocs Limited keeps $12 of every $100 of revenue as net profit.

Cash quality

1.3×

Cash from Amdocs Limited's business was 1.3× its reported profit in the year to Sep 2025 — its profit turned into cash.

Interest cover

19.1×

Amdocs Limited's operating profit covered its interest costs 19.1 times in the year to Sep 2025.

Cash vs debt

Net debt

Amdocs Limited had $501 M more debt than cash (net debt) at Sep 2025.

Questions

What is Amdocs Limited's P/E ratio?

Investors pay $15.1 for every $1 of Amdocs Limited's yearly profit, lower than 84% of Technology companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Amdocs Limited: $6.6 B ÷ $3.3 B (30 Jun 2026) = 2.0.

What is Amdocs Limited's return on equity?

Amdocs Limited earned 13.3% on its shareholders' money over the last year, higher than 70% of Technology companies in United States.

How much does Amdocs Limited owe compared with what it owns?

Amdocs Limited owes $0.48 for every $1 it owns (low), higher than 52% of Technology companies in United States.

Does Amdocs Limited pay a dividend?

Yes. Amdocs Limited pays 3.70% of its share price as dividends a year, higher than 91% of dividend-paying Technology companies in United States.

Is Amdocs Limited's revenue growing?

Revenue fell 9% in the year to Sep 2025, and shrank 0% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.